Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. - sprookjes - yvandenbroek - TriplyDB

Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.

Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.

http://www.wikidata.org/entity/Q34848818

about

Fragile x syndrome Systematic review of pharmacological treatments in fragile X syndrome Fragile X syndrome and targeted treatment trials.Unstable mutations in the FMR1 gene and the phenotypes A novel function for fragile X mental retardation protein in translational activation Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures Gene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms.Crosstalk between JNK and SUMO signaling pathways: deSUMOylation is protective against H2O2-induced cell injury.Antityphoid and radical scavenging properties of the methanol extracts and compounds from the aerial part of Paullinia pinnata.A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers Behavioral and synaptic circuit features in a zebrafish model of fragile X syndrome.Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters.Modulation of dendritic spines and synaptic function by Rac1: a possible link to Fragile X syndrome pathology.FMR1 premutation and full mutation molecular mechanisms related to autism.Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.An Abnormal Nitric Oxide Metabolism Contributes to Brain Oxidative Stress in the Mouse Model for the Fragile X Syndrome, a Possible Role in Intellectual Disability.Histopathological studies of acute and chronic effects of Calliandra portoricensis leaf extract on the stomach and pancreas of adult Swiss albino mice.Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons Promiscuous or discriminating: Has the favored mRNA target of Fragile X Mental Retardation Protein been overlooked?Imbalance between Glutamate and GABA in Fmr1 Knockout Astrocytes Influences Neuronal Development.MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.Antioxidant treatment strategies for hyperphenylalaninemia.Advances in the development of novel antioxidant therapies as an approach for fetal alcohol syndrome prevention.From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.Treatment of the psychiatric problems associated with fragile X syndrome.Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity.Biologic Stress, Oxidative Stress, and Resistance to Drugs: What Is Hidden Behind.Expression Levels of the Oxidative Stress Response Gene ALDH3A2 in Granulosa-Lutein Cells Are Related to Female Age and Infertility Diagnosis.Long-term alpha-tocopherol supplements may improve mental development in extremely low birthweight infants.Pharmacological Rescue of Hippocampal Fear Learning Deficits in Fragile X Syndrome.Aberrant Rac1-cofilin signaling mediates defects in dendritic spines, synaptic function, and sensory perception in fragile X syndrome.Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.Antigenotoxic and Antioxidant Activity of Methanol Stem Bark Extract of Napoleona Vogelii Hook & Planch (Lecythidaceae) In Cyclophosphamide-Induced Genotoxicity.Potential Involvement of Impaired BKCa Channel Function in Sensory Defensiveness and Some Behavioral Disturbances Induced by Unfamiliar Environment in a Mouse Model of Fragile X Syndrome.Males but not females show differences in calbindin immunoreactivity in the dorsal thalamus of the mouse model of fragile X syndrome.Genome-wide association mapping of heritable temperament variation in the Tennessee Walking Horse.Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice.

P2860

Q24633000-A5829871-AB4B-4D16-8E64-28F5853C1FD0 Q24647106-5601761A-995B-442F-A982-80B9550EFC09 Q26865162-41F5C853-267C-4DE0-B2E5-F817B849E83F Q26996649-E12FA407-A376-4C72-96FE-E91F2A0E708B Q28118268-112813C8-3875-402E-8886-4520A71C86AC Q30500501-B9C38E5F-AE94-4096-850C-F75997E3C51F Q30885784-982BBB31-C9D8-4CBF-BF0F-6BAB2D8D2430 Q33650170-24278EA4-2006-4835-A691-5DB9CB5DE386 Q33997473-908B8A37-E367-42BE-AFA8-7DD9974DE7C7 Q34099050-C256C6B8-70FF-43EE-904A-E3ABD7EC1359 Q34172158-E393958B-67B0-4BA1-B1C0-2476DD777597 Q34207747-DB0701B2-0C58-48BA-BF4F-E73272606E9C Q34575595-B11A680E-5DD0-4D1A-9BF3-5F78C600D031 Q34638909-FE27FC35-1118-4671-B721-597F8DB7866A Q34837762-650C66DD-9E11-4B21-86B5-17BD658D5153 Q35090220-1E8B3402-769B-4DE9-BAF4-7A8672368C8A Q35680720-77B83AF6-569E-474B-918D-46064DB6B891 Q36283892-5DA71335-AD7A-4A84-A501-EB20A15007F3 Q36405697-7E61DEA0-EE82-4FE1-A4A1-786F35BD0C27 Q36719420-ED478A86-2D89-4DDE-A738-028C695751E2 Q37065097-348D7AD8-9954-418D-8BB9-2705CBF2218C Q37065318-F799225F-58E4-4B64-A193-4C7DB9A5A28B Q37208978-A041C4A5-44A6-4784-8F68-7C736AFFF30B Q37617682-05F7805F-EA26-4815-8710-A5AF8DA04845 Q38105266-2DC9B364-931C-448C-8503-20C01C55B701 Q38240743-074BA44A-86B9-4F2E-BB28-5DCECBC272D3 Q38263473-AA8F81F0-7311-43AC-951C-21507A291479 Q38324675-96381448-B22C-43FC-8D6D-5CF05BAD6AC8 Q38344922-4527AA4F-354E-42BB-A7A6-8F914E7C9B8B Q39144316-6F9E3730-CC02-4E2E-8304-F8FE35444534 Q40451384-BC780A9A-1DA3-4CF9-90C3-12AB40CA7AA8 Q45220636-BA04BAEE-7664-450E-BE59-0D454E1E1B34 Q47412555-37B7CCC8-478E-4229-881D-D11FB69B2BCF Q47587415-1F7F73B6-6A89-4669-97EB-AF3935CAC3B6 Q47674165-00A15964-5238-4B82-86B0-86A3179554EA Q47703923-37FD8D50-89D0-4837-958A-AF51F0442198 Q48104405-3FC86A11-8ACF-4502-999D-CEEA6B2CE820 Q48411438-5B09B10C-B6A0-45E8-B4D0-B8DDE2E76E9B Q48825270-7182F1A3-31B1-422E-A2ED-CF11FF26DE7B Q51012749-541619E3-2F5A-446C-B67D-B5E1D6159AD2

P2860

Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.

http://www.wikidata.org/entity/Q34848818

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@ast

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@en

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@nl

type

label

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@ast

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@en

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@nl

prefLabel

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@ast

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@en

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@nl

P1433

Q34848818-87A1F3F2-CAF9-4864-B1E6-E9D2A49F2EA9

P1476

Q34848818-8B8FA1CA-13FA-4BA9-ABFB-F4148DA82D00

P2093

Q34848818-1FECAA39-205F-4F3B-9399-674882BB9FFD

Q34848818-60E5519D-C19C-4455-AB3C-4705D788AB64

Q34848818-64290347-23A0-432E-8ECF-4A361E7D631C

Q34848818-73F44A5F-AD4F-4328-B39C-EC9BE0560D11

Q34848818-B9E86D7A-9455-4DFB-8488-23BC3CACA764

Q34848818-C148B351-C976-4377-8C09-BDA32CCADFEE

Q34848818-E760F01A-78F6-4212-8E90-009A75540BC2

P2860

Q34848818-15248888-964A-4F29-9740-19087910C04B

Q34848818-154FC549-4A65-49CC-A565-07F417684F00

Q34848818-15B0A07F-FE46-44BD-929C-F7E0CA614362

Q34848818-1ADEFE2A-47B3-438D-8C67-C767A70A794B

Q34848818-1E3D6667-7AA4-4785-8913-8F3CB31C2E7B

Q34848818-2118E314-CB3C-4EC8-885C-AE0F539FEA98

Q34848818-218B2DCC-0185-4B96-9370-5C284F1917E2

Q34848818-23684D9A-BD59-424C-870A-B6F6B697C1A8

Q34848818-24590874-88BB-4EE9-958C-2F83EF44CDCF

Q34848818-3502601D-5DD1-415A-8D1B-BD567EEE485E

P2888

Q34848818-4FE14E2B-BCD0-4524-B1A1-3B10390553F4

P304

Q34848818-9D0D3D99-0032-4787-A270-421F765F2285

P31

Q34848818-00FD027A-9C31-4369-9A4E-687B37D28B38

P356

Q34848818-3C85C141-174A-4632-8E7C-ACCE5387A26A

P407

Q34848818-A5CCD7B3-C278-4BA8-A5BB-2C7057726C25

P433

Q34848818-7D0F7D6C-3E02-4D0A-B77D-C637A5128FD1

P478

Q34848818-B5B7FD02-378D-43CD-BEA7-32CEC274C8B6

P577

Q34848818-7BC76303-30D2-4C83-AF19-5A6A24208371

P6179

Q34848818-C711BE5B-F9E8-47D9-8222-2E6A98DB9FF7

P698

Q34848818-6EBBFC66-1E4E-4CAC-9747-ECC308A1F4EE

P921

Q34848818-0157D172-5131-4BEA-8E6B-884FA4D22C29

P356

P1433

Neuropsychopharmacology

P1476

Alpha-tocopherol protects agai ...... roach for the Fmr1 deficiency.

@en

P2093

Fernando Rodriguez-de Fonseca

http://www.w3.org/2001/XMLSchema#string

Ignacio del Arco-Herrera

http://www.w3.org/2001/XMLSchema#string

Juan Decara

http://www.w3.org/2001/XMLSchema#string

Lourdes Sanchez

http://www.w3.org/2001/XMLSchema#string

Rajaa el Bekay

http://www.w3.org/2001/XMLSchema#string

Yanina Romero-Zerbo

http://www.w3.org/2001/XMLSchema#string

Yolanda de Diego-Otero

http://www.w3.org/2001/XMLSchema#string

P2860

Correction of fragile X syndrome in mice.

Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation

Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice.

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability

Physiology and neurobiology of stress and adaptation: central role of the brain

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.

NOX enzymes and the biology of reactive oxygen

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning

P2888

P304

1011-1026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2008.152

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036955132

http://www.w3.org/2001/XMLSchema#string

P698

18843266

http://www.w3.org/2001/XMLSchema#string

P921